CORRECTING and REPLACING PAVmed to Hold Business Update Conference Call on August 12, 2021
Company conference call and webcast at EDT 4:30PM EDT NEW YORK--(BUSINESS WIRE)--$pavm #earnings--First paragraph, first sentence of release should read:...
News
PAVmed to Hold Business Update Conference Call on August 12, 2021
Company conference call and webcast at EDT 4:30PM EDT NEW YORK--(BUSINESS WIRE)--$pavm #earnings--PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or...
VIVIS-Brand CBD Products Will Be Available at Festival Foods Flagship Store
KATY, TX / ACCESSWIRE / August 2, 2021 / Neutra Corp. (OTC PINK:NTRR) announces it has been officially accepted in...
DSS Continues to Grow its Healthcare Segment through $1M Investment in Vivacitas Oncology
ROCHESTER, NY / ACCESSWIRE / August 2, 2021 / Document Security Systems, Inc. ("DSS" or the "Company") (NYSE American:DSS), a...
Sanara MedTech Inc. Announces Second Quarter 2021 Earnings Release and Conference Call Dates
FORT WORTH, TX / ACCESSWIRE / August 2, 2021 / Sanara MedTech Inc.Based in Fort Worth, Texas, Sanara MedTech Inc....
ENDRA Life Sciences to Report Second Quarter 2021 Financial Results on August 12, 2021
ANN ARBOR, MI / ACCESSWIRE / August 2, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of enhanced...
Celcuity Inc. Schedules Release of Second Quarter 2021 Financial Results and Webcast
MINNEAPOLIS, MN / ACCESSWIRE / August 2, 2021 / Celcuity Inc. (Nasdaq:CELC), a clinical-stage biotechnology company pursuing an integrated companion...
1933 Industries to Hold Extraordinary Meeting of Debentureholders and Recommends Holders to Vote in Favor of the Proposed Amendment
The amendment seeks to complete the one-year extension of the maturity date of the debenturesVANCOUVER, BC / ACCESSWIRE / August...
Sorrento Receives FDA Authorization to Start Phase 1 Clinical Trial of Proprietary, “Off-the-Shelf”, Allogeneic anti-CD38 DAR-T (Dimeric Antigen Receptor-T) Cell Therapy to Treat Relapsed or Refractory Multiple Myeloma
First allogeneic, off-the-shelf anti-CD38 DAR-T cell therapy cleared for Phase 1 clinical trial in Relapsed or Refractory Multiple Myeloma.CD38 DAR-T...
Castellum Announces Award of SeaPort-NxG Contract to Corvus Subsidiary
Castellum Awarded US Navy SeaPort-NxG Contract to Corvus Subsidiary Castellum, Inc. (OTC: ONOV) announces that its subsidiary Corvus Consulting has...
Meridian Closes Acquisition of BreathTek® Business
CINCINNATI, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life...
Coloplast to Donate $150,000 to Twin Cities Nonprofits Via New Community Engagement Program
Funds will support charitable organizations that offer programs focused on developing science, technology, engineering, and math (STEM) skills in underserved...
Praxis Precision Medicines to Present at 2021 Wedbush PacGrow Healthcare Conference
CAMBRIDGE, Mass., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic...
Sema4 to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021
STAMFORD, Conn., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a patient-centered health intelligence company leveraging AI and machine...
Keros Therapeutics Appoints Simon Cooper, M.B.B.S. as Chief Medical Officer
LEXINGTON, Mass., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on...
Resonant To Report Second Quarter 2021 Financial Results on Wednesday, August 11th at 3:30 P.M. Central Time
AUSTIN, Texas, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a provider of radio frequency (RF) filter solutions...
ChemoCentryx to Hold Second Quarter 2021 Financial Results Conference Call on Monday, August 9, 2021
MOUNTAIN VIEW, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's second quarter...
Carrick Therapeutics Announces Collaboration with Roche to Evaluate Novel Samuraciclib Combination to Treat HR+ Breast Cancer
Collaboration leverages Roche’s MORPHEUS platform to accelerate development of samuraciclib in combination with Roche’s giredestrantDUBLIN, Ireland and BOSTON, Aug. 02,...
Phathom Pharmaceuticals to Participate in the BMO Biopharma Spotlight Series: Innovation in GI
FLORHAM PARK, N.J., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused...
Allogene Therapeutics Appoints Industry Leaders Elizabeth (Liz) Barrett and Vicki Sato, Ph.D., to its Board of Directors
Collective Expertise in Strategic Development and Commercialization Will Guide Preparation of the Industry’s First Potentially Pivotal Allogeneic CAR T Trial...